CLINICAL_TRIALS
trial_result
· 2007-02-13
Clinical Trial Update: Ezetimibe and Simvastatin in Dyslipidemia of Diabetes [Phase 2]
Summary
A Phase 2 trial evaluating ezetimibe in combination with simvastatin for dyslipidemia in type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED